Do Antiepileptic Drugs Change the Levels of Arginine Derivatives in Epileptic Children Treated with Polytherapy? The Results of a Case–Control Study

Previously, a relation between therapy with antiepileptic drugs (AEDs) and the levels of biochemical parameters was observed in adult patients suffering from epilepsy. Among these biochemical factors, arginine derivatives are often analyzed, i.e., asymmetric dimethylarginine (ADMA), symmetric dimeth...

Full description

Bibliographic Details
Main Authors: Beata Sarecka-Hujar, Izabela Szołtysek-Bołdys, Ilona Kopyta
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Children
Subjects:
Online Access:https://www.mdpi.com/2227-9067/9/11/1709
_version_ 1797468629337374720
author Beata Sarecka-Hujar
Izabela Szołtysek-Bołdys
Ilona Kopyta
author_facet Beata Sarecka-Hujar
Izabela Szołtysek-Bołdys
Ilona Kopyta
author_sort Beata Sarecka-Hujar
collection DOAJ
description Previously, a relation between therapy with antiepileptic drugs (AEDs) and the levels of biochemical parameters was observed in adult patients suffering from epilepsy. Among these biochemical factors, arginine derivatives are often analyzed, i.e., asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA), and homoarginine (hArg) as they may be linked with increased risk for cardiovascular disease (CVD). Since the levels of arginine derivatives may increase during therapy, and the treatment of epilepsy often lasts many years, patients may experience CVD faster. The aim of the present study was to analyze the levels of arginine derivatives in children with epilepsy who were treated with multiple AEDs to answer the question whether pediatric patients may be at increased risk of CVD in the future. We prospectively analyzed 21 children suffering from epilepsy who took ≥2 AEDs for at least 6 months and 22 children without epilepsy (reference group). The levels of the arginine derivatives, e.g., ADMA, SDMA, and hArg, were determined in the blood serum using the HPLC method. No differences in both the mean levels of ADMA and SDMA, as well as in the mean values of the arginine derivative ratios, were observed between the groups. The tendency toward a lower level of hArg was found in epileptic patients more than in the reference group (<i>p</i> = 0.091). Epileptic children receiving three or more AEDs had significantly lower concentrations of hArg and values of the hArg/ADMA ratio than the reference group (<i>p</i> = 0.023 and <i>p</i> = 0.006, respectively). In turn, the mean hArg/ADMA ratio was lower in children receiving three or more AEDs compared to children receiving two AEDs (<i>p</i> = 0.002). There was also a positive correlation between the hArg and ADMA concentrations in children with epilepsy taking two AEDs; the higher the level of hArg, the greater the level of ADMA on average (r = 0.650, <i>p</i> = 0.022). Taking three or more AEDs by epileptic children resulted in lower levels of both hArg and the value of the hArg/ADMA ratio.
first_indexed 2024-03-09T19:10:08Z
format Article
id doaj.art-31d88b3506834e7eba56c00008e229ed
institution Directory Open Access Journal
issn 2227-9067
language English
last_indexed 2024-03-09T19:10:08Z
publishDate 2022-11-01
publisher MDPI AG
record_format Article
series Children
spelling doaj.art-31d88b3506834e7eba56c00008e229ed2023-11-24T04:12:33ZengMDPI AGChildren2227-90672022-11-01911170910.3390/children9111709Do Antiepileptic Drugs Change the Levels of Arginine Derivatives in Epileptic Children Treated with Polytherapy? The Results of a Case–Control StudyBeata Sarecka-Hujar0Izabela Szołtysek-Bołdys1Ilona Kopyta2Department of Basic Biomedical Science, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, 41-200 Sosnowiec, PolandDepartment of General and Inorganic Chemistry, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, 41-200 Sosnowiec, PolandDepartment of Pediatric Neurology, Faculty of Medical Sciences in Katowice, Medical University of Silesia in Katowice, Katowice, 40-752 Katowice, PolandPreviously, a relation between therapy with antiepileptic drugs (AEDs) and the levels of biochemical parameters was observed in adult patients suffering from epilepsy. Among these biochemical factors, arginine derivatives are often analyzed, i.e., asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA), and homoarginine (hArg) as they may be linked with increased risk for cardiovascular disease (CVD). Since the levels of arginine derivatives may increase during therapy, and the treatment of epilepsy often lasts many years, patients may experience CVD faster. The aim of the present study was to analyze the levels of arginine derivatives in children with epilepsy who were treated with multiple AEDs to answer the question whether pediatric patients may be at increased risk of CVD in the future. We prospectively analyzed 21 children suffering from epilepsy who took ≥2 AEDs for at least 6 months and 22 children without epilepsy (reference group). The levels of the arginine derivatives, e.g., ADMA, SDMA, and hArg, were determined in the blood serum using the HPLC method. No differences in both the mean levels of ADMA and SDMA, as well as in the mean values of the arginine derivative ratios, were observed between the groups. The tendency toward a lower level of hArg was found in epileptic patients more than in the reference group (<i>p</i> = 0.091). Epileptic children receiving three or more AEDs had significantly lower concentrations of hArg and values of the hArg/ADMA ratio than the reference group (<i>p</i> = 0.023 and <i>p</i> = 0.006, respectively). In turn, the mean hArg/ADMA ratio was lower in children receiving three or more AEDs compared to children receiving two AEDs (<i>p</i> = 0.002). There was also a positive correlation between the hArg and ADMA concentrations in children with epilepsy taking two AEDs; the higher the level of hArg, the greater the level of ADMA on average (r = 0.650, <i>p</i> = 0.022). Taking three or more AEDs by epileptic children resulted in lower levels of both hArg and the value of the hArg/ADMA ratio.https://www.mdpi.com/2227-9067/9/11/1709epilepsychildrenADMASDMAhomoargininearginine derivatives
spellingShingle Beata Sarecka-Hujar
Izabela Szołtysek-Bołdys
Ilona Kopyta
Do Antiepileptic Drugs Change the Levels of Arginine Derivatives in Epileptic Children Treated with Polytherapy? The Results of a Case–Control Study
Children
epilepsy
children
ADMA
SDMA
homoarginine
arginine derivatives
title Do Antiepileptic Drugs Change the Levels of Arginine Derivatives in Epileptic Children Treated with Polytherapy? The Results of a Case–Control Study
title_full Do Antiepileptic Drugs Change the Levels of Arginine Derivatives in Epileptic Children Treated with Polytherapy? The Results of a Case–Control Study
title_fullStr Do Antiepileptic Drugs Change the Levels of Arginine Derivatives in Epileptic Children Treated with Polytherapy? The Results of a Case–Control Study
title_full_unstemmed Do Antiepileptic Drugs Change the Levels of Arginine Derivatives in Epileptic Children Treated with Polytherapy? The Results of a Case–Control Study
title_short Do Antiepileptic Drugs Change the Levels of Arginine Derivatives in Epileptic Children Treated with Polytherapy? The Results of a Case–Control Study
title_sort do antiepileptic drugs change the levels of arginine derivatives in epileptic children treated with polytherapy the results of a case control study
topic epilepsy
children
ADMA
SDMA
homoarginine
arginine derivatives
url https://www.mdpi.com/2227-9067/9/11/1709
work_keys_str_mv AT beatasareckahujar doantiepilepticdrugschangethelevelsofargininederivativesinepilepticchildrentreatedwithpolytherapytheresultsofacasecontrolstudy
AT izabelaszołtysekbołdys doantiepilepticdrugschangethelevelsofargininederivativesinepilepticchildrentreatedwithpolytherapytheresultsofacasecontrolstudy
AT ilonakopyta doantiepilepticdrugschangethelevelsofargininederivativesinepilepticchildrentreatedwithpolytherapytheresultsofacasecontrolstudy